Repligen: Some Thoughts for 2021 (RGEN, $223.28)Tuesday, March 2, 2021 · 7:04 am |
|
Repligen Stock Price Surges on Announcement of Preliminary 1Q, 2010 Results and Acquisition of CT Technologies (RGEN, Buy, $68.61)Monday, April 29, 2019 · 10:00 am |
|
Repligen: More Detailed Analysis on GE Decision to Manufacture Protein AThursday, September 28, 2017 · 9:11 am |
|
Repligen: Market Likes Spectrum Acquisition and So Do I (RGEN, Buy, $43.20)Tuesday, June 27, 2017 · 12:08 pm |
|
Repligen: A Business Update and Reiteration of Buy (RGEN, Buy, $34.11)Friday, April 7, 2017 · 4:10 pm |
|
SmithOnStocks Top Stock Picks for 2017, January 3, 2017Tuesday, January 3, 2017 · 10:18 am |
|
Repligen: Very Strong Growth in Sales and Earnings Continues (RGEN, 29.37, Buy)Wednesday, August 10, 2016 · 2:46 pm |
|
Repligen: A Detailed Update; Recent Price Drop Makes Me More Positive (RGEN, Buy, $28.50Wednesday, December 2, 2015 · 8:11 am |
|
Repligen: Fundamentals Are Exceptional But The Stock Carries A Premium Valuation (RGEN, $39.97, For Paid Subscribers)Thursday, July 9, 2015 · 8:44 am |
|
Repligen Makes An Excellent Acquisition (RGEN, Hold/ Buy, $19.04, free content)Tuesday, June 3, 2014 · 11:29 am |
|
Repligen Has an Outstanding, Stable Business and Excellent Long Term Growth Potential (RGEN, Hold/ Buy, $14.07, Paid Subscribers Only)Monday, April 7, 2014 · 3:45 pm |
|
San Francisco Trip Is the Basis for a Preview of 2014 (Subscribers Only)Wednesday, January 22, 2014 · 3:48 pm |
|
Repligen: Looking At 2014 and Beyond- Potential for EPS Growth (RGEN, $12.78) (Subscribers Only)Tuesday, November 19, 2013 · 11:25 am |
|
Repligen: A Buy and Hold Stock: OPUS Promises to be a Dynamic New Product (RGEN; $9.87)Monday, August 19, 2013 · 11:32 am |
|
Repligen Promises To Be a Cash Flow Machine (RGEN, $6.88)Tuesday, April 2, 2013 · 3:30 pm |
|
Repligen: Initiating Coverage with a Buy (RGEN, Buy, $6.13)Tuesday, December 4, 2012 · 12:35 pm |
|
There are 16 reports on file. |